# Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia.

> **NCT02648113** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 668 (actual)

## Conditions studied

- Myocardial Infarction
- Anemia
- Blood Transfusion

## Interventions

- **PROCEDURE:** Restrictive transfusion
- **PROCEDURE:** Liberal transfusion
- **BIOLOGICAL:** red blood transfusion

## Key facts

- **NCT ID:** NCT02648113
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-23
- **Primary completion:** 2019-10-10
- **Final completion:** 2020-09-10
- **Target enrollment:** 668 (ACTUAL)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648113, "Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02648113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*